You can find more details about the speakers on the Live Talks page, and make sure to mark your calendar Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023 InterAx Biotech

prestigious international award – exemplified by the fact that other winners this year are the co-founders of BioNTech

curriculum with your topic suggestions Weekly new releases  to stay ahead of the science Content built for biotech

If you’re in GPCR discovery or biotech R&D, this is a masterclass in turning deep science into scalable David Parker spent years designing rare-earth europium probes. Partnerships, Not Just Sponsorships Behind every breakthrough assay is a web of collaborations that rarely

Pairaudeau, CTO of Exscientia discuss transforming drug discovery using their AI-driven platform Salipro Biotech

with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and

26RFa by the pyroglutamylated RFamide peptide receptor Industry News NanoImaging Services and Cube Biotech

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

When a compound’s off-rate is slower than its clearance, its biological effect outlives its plasma presence The on-rate/off-rate balance  matters: too tight, and penetration stalls; too loose, and efficacy dissipates The metrics shift: k_inact  (rate of inactivation) replaces static Ki values. k_inact/KI  becomes the Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full

Kenakin Content trusted by biotech, pharma & academia 💎 $2999/year — one conference cost = a full

Mid-2025 How GPCR agonists, including antibodies, are shaping the future of metabolic care Salipro Biotech

Discovery programs rarely fail because a molecule “did nothing.” Biology rarely gives one. It equips pharmacologists, discovery teams, and biotech leaders to see around mechanistic corners, recognize

Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full

Industry News Orion Biotechnology at the AACR 2023. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) NEW ASPET 2023 - American Society for Pharmacology

Visit in its clinical phase 2b trial with AEF0117 for the treatment of cannabis use disorder Orion Biotechnology will be presenting at the 19th Biopharma Drug Discovery Nexus Salipro Biotech will participate in BioKorea2024

Showcases Innovative AI-Driven Drug Design at BRIC AI 2023 Workshop Salipro Biotech AB Celebrates Milestones

(April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) ASPET 2023 - American Society for Pharmacology

neutrophils by promoting an alternative-like polarization during bacterial infection Industry News InterAx Biotech's

Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer obesity drug program have started a new biotech

(April 20 - 21, 2023) NEW Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

Industry News Josephine (Pina) Cardarelli from GPCR Therapeutics on Beyond Biotech Podcast Crinetics

in Upcoming Investor and Industry Conferences Sosei and IPJ to become Nxera Pharma from April Orion Biotechnology will be at the BIO CEO & Investor Conference Salipro Biotech AB will be at the Oxford Global’s Biologics

Secures VLAIO Grant Supporting Drug Discovery & Development In Endocrine And Metabolic Diseases How biotech

July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional

.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Brusle, Brussels, Belgium, has been named the winner of Brandeis’ 24th Jacob and Louise Gabbay Award in Biotechnology of one of the biggest classes of pharmaceutical targets by combining structural biology and advanced biotechnology

June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development

of Alcohol and Substance Use Disorders AbbVie recruits a GPCR team in Oxford, buying out a fledgling biotech

December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company